Melanopsin retinal ganglion cell loss in Alzheimer disease

Melanopsin retinal ganglion cells (mRGCs) are photoreceptors driving circadian photoentrainment, and circadian dysfunction characterizes Alzheimer disease (AD). We investigated mRGCs in AD, hypothesizing that they contribute to circadian dysfunction.

• Publication year

  2015

• Venue

  Annals of Neurology

• Publication date

  2015-12-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ana.24548PMID 26505992PMCID 4737313
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Rest-Activity Rhythm and Physical Activity in Early-Onset Dementia

  2015cited by this paper
• Sleep is related to neuron numbers in the ventrolateral preoptic/intermediate nucleus in older adults with and without Alzheimer's disease.

  2014cited by this paper
• Detection of Retinal Nerve Fiber Layer Defects in Alzheimer’s Disease Using SD-OCT

  2014cited by this paper
• Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia.

  2014cited by this paper
• Central projections of intrinsically photosensitive retinal ganglion cells in the macaque monkey

  2014cited by this paper
• Ocular changes in TgF344-AD rat model of Alzheimer's disease.

  2014cited by this paper
• Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography.

  2013cited by this paper
• Retinal Nerve Fiber Layer Thickness in Patients With Alzheimer Disease

  2013cited by this paper
• The pupil light reflex in Leber's hereditary optic neuropathy: evidence for preservation of melanopsin-expressing retinal ganglion cells.

  2013cited by this paper
• Diverse types of ganglion cell photoreceptors in the mammalian retina.

  2012cited by this paper
• Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice

  2012cited by this paper
• Structural and functional impairment of the retina and optic nerve in Alzheimer's disease.

  2012cited by this paper
• Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy Assessment

  2012cited by this paper
• Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease

  2011cited by this paper
• Intrinsically photosensitive (melanopsin) retinal ganglion cell function in glaucoma.

  2011cited by this paper
• National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

  2011cited by this paper
• Neurodegeneration of the retina in mouse models of Alzheimer’s disease: what can we learn from the retina?

  2011cited by this paper
• Melanopsin-expressing retinal ganglion cells: implications for human diseases.

  2011cited by this paper
• Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.

  2011cited by this paper
• Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease.

  2011cited by this paper
• Circadian rhythms, aging, and life span in mammals.

  2011cited by this paper
• P2‐190: Use of an FDG‐PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

  2011cited by this paper
• Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women

  2011cited by this paper
• Intrinsically photosensitive retinal ganglion cells: many subtypes, diverse functions.

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Alzheimer's disease.

  2010cited by this paper
• Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies.

  2010cited by this paper
• Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography.

  2010cited by this paper
• Cholinergic deficiency in Alzheimer's and Parkinson's disease: evaluation with pupillometry.

  2009cited by this paper
• Antibody Elution Method for Multiple Immunohistochemistry on Primary Antibodies Raised in the Same Species and of the Same Subtype

  2009cited by this paper
• Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.

  2009cited by this paper
• Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease.

  2008cited by this paper
• Melatonin and Bright‐Light Treatment for Rest–Activity Disruption in Institutionalized Patients with Alzheimer's Disease

  2008influential reference
• Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia.

  2008cited by this paper
• Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease.

  2007cited by this paper
• Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease.

  2007cited by this paper
• Retinal abnormalities in early Alzheimer's disease.

  2007cited by this paper
• Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT.

  2007cited by this paper
• G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences

  2007cited by this paper
• Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the “master clock”

  2006cited by this paper
• Relationship between Cognitive Impairment and Retinal Morphological and Visual Functional Abnormalities in Alzheimer Disease

  2006cited by this paper
• Age-related decline of human optic nerve axon populations

  2006cited by this paper
• Effect of morning bright light treatment for rest–activity disruption in institutionalized patients with severe Alzheimer's disease

  2005cited by this paper
• Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN

  2005cited by this paper
• Neuronal input pathways to the brain's biological clock and their functional significance.

  2005cited by this paper
• Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy.

  2005cited by this paper
• Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia.

  2004influential reference
• Melanopsin is expressed in PACAP-containing retinal ganglion cells of the human retinohypothalamic tract.

  2004cited by this paper
• Melanopsin retinal ganglion cells and the maintenance of circadian and pupillary responses to light in aged rodless/coneless (rd/rd cl) mice

  2003cited by this paper
• On counting and counting errors

  2002cited by this paper
• Neurotransmitters of the retino-hypothalamic tract

  2002cited by this paper
• Melanopsin-Containing Retinal Ganglion Cells: Architecture, Projections, and Intrinsic Photosensitivity

  2002cited by this paper
• High Occurrence Rate of Glaucoma among Patients with Alzheimer’s Disease

  2002cited by this paper
• Phototransduction by Retinal Ganglion Cells That Set the Circadian Clock

  2002cited by this paper
• Sundowning and circadian rhythms in Alzheimer's disease.

  2001cited by this paper
• Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia.

  1999cited by this paper
• Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods.

  1999cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

  1997cited by this paper
• Methods for determining numbers of cells and synapses: A case for more uniform standards of review

  1996cited by this paper
• Any way you cut it: A new journal policy for the use of unbiased counting methods

  1996cited by this paper
• Circadian rest-activity rhythm disturbances in Alzheimer's disease.

  1996cited by this paper
• Visual field loss in senile dementia of the Alzheimer's type

  1995cited by this paper
• Sleep/wake patterns In Alzheimer's disease: relationships with cognition and function

  1995cited by this paper
• Staging of Alzheimer's disease-related neurofibrillary changes.

  1995cited by this paper
• Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease.

  1995cited by this paper
• EEG markers of early Alzheimer's disease in computer selected tonic REM sleep.

  1992cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Optic nerve damage in Alzheimer's disease.

  1990cited by this paper
• Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease.

  1990cited by this paper
• Retinal ganglion cell degeneration in Alzheimer's disease.

  1989cited by this paper
• Chronic human glaucoma causing selectively greater loss of large optic nerve fibers.

  1988cited by this paper
• Optic-nerve degeneration in Alzheimer's disease.

  1986cited by this paper
• The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia.

  1985cited by this paper
• A retinohypothalamic pathway in man: light mediation of circadian rhythms.

  1984cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Morpho-Functional Characterization and miRNA Profiling of the Retina in the 5xFAD Murine Model of Alzheimer's Disease

  2026cites this paper
• Early proteomic signatures of Alzheimer’s disease in the retina and brain of 3xTg-AD mice

  2026cites this paper
• A timeline of structural and functional consequences to ipRGCs in a mouse model of Alzheimer's disease.

  2026cites this paper
• Unlocking ocular biomarkers for early detection of Alzheimer's disease

  2025cites this paper
• Diagnostic performance of actigraphy in Alzheimer’s disease using a machine learning classifier – a cross-sectional memory clinic study

  2025cites this paper
• Axonal degeneration and retinal neurovascular dysfunction in the TgF344-AD rat model of Alzheimer's disease

  2025cites this paper
• Reduced retinal thickness and risk of Alzheimer’s disease: a bidirectional two-sample Mendelian randomization study

  2025cites this paper
• Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer’s disease retina

  2025cites this paper
• Functional and morphological alterations of the light perception circuits in postmortem retina from donors at different stages of Alzheimer’s disease

  2025influential citation
• Retinal manifestations and their diagnostic significance in Alzheimer's disease

  2025cites this paper
• The role of RGC degeneration in the pathogenesis of glaucoma

  2025cites this paper
• Retinal and Optic Nerve Lesions Correspond to Amyloid in Autosomal Dominant Alzheimer's Disease

  2025cites this paper
• Integrated analysis of in vivo retinal perivascular amyloid imaging and cognition

  2025cites this paper
• Wearables in Chronomedicine and Interpretation of Circadian Health

  2025cites this paper
• Hyperspectral retinal imaging to detect Alzheimer’s disease in a memory clinic setting

  2025cites this paper
• Melatonin Supplementation in Alzheimer’s disease: The Potential Role in Neurogenesis

  2025cites this paper
• Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging

  2025cites this paper
• Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer’s disease retina

  2025cites this paper
• Recent Advances in Visual Dysfunction and Ocular Biomarkers in Neurological Disorders

  2025cites this paper
• Retinal tau phosphorylation in Alzheimer’s disease: a mass spectrometry study

  2025cites this paper
• Reconstructed cell-type-specific rhythms in human brain link Alzheimer's pathology, circadian stress, and ribosomal disruption.

  2025cites this paper
• Detecting cognitive impairment in diabetics based on retinal photos by a deep learning method

  2025cites this paper
• Exploring the relationship between melanopsin gene variants, sleep, and markers of brain health

  2025cites this paper
• Ocular changes as potential biomarkers for early diagnosis of Alzheimer's disease

  2025influential citation
• Global trends and prospects of ocular biomarkers in Alzheimer’s disease: a bibliometric analysis

  2025cites this paper
• Three-Dimensional β-Amyloid Burden Correlation Between the Eye and Brain in Alzheimer's Disease Mice Using Light-Sheet Fluorescence Microscopy

  2025cites this paper
• Retinal biomarkers for the risk of Alzheimer’s disease and frontotemporal dementia

  2025cites this paper
• Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer’s disease

  2025cites this paper
• Retinal Ganglion Cell Diversity in Disease: Clinical Implications and Type-Specific Evaluation.

  2025cites this paper
• New Research on Biomarkers in Alzheimer's Continuum.

  2025cites this paper
• The Retinal Dopaminergic Circuit as a Biomarker for Huntington’s and Alzheimer’s Diseases

  2025cites this paper
• The Intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders.

  2025cites this paper
• Fluorescence lifetime imaging ophthalmoscopy adds the retina to cortical pathology for visual dysfunction in neurodegenerative diseases

  2025cites this paper
• Chronobiology and Neurodegeneration: The Role of Melatonin in Alzheimer's Disease

  2025cites this paper
• Anatomy-driven segmentation of parafoveal optical coherence tomography (OCT) measures may improve associations with clinical outcomes in multiple sclerosis

  2025cites this paper
• Retinal nerve fibre layer thickness is associated with attention and predicts risk states of dementia

  2025cites this paper
• The interplay between circadian rhythms and aging: molecular mechanisms and therapeutic strategies

  2025cites this paper
• Blood–Brain Barrier (BBB) Dysfunction in CNS Diseases: Paying Attention to Pericytes

  2025cites this paper
• Association of circadian dysregulation with retinal degeneration and Alzheimer’s disease: a special focus on Muller glial cells

  2024cites this paper
• Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer’s disease

  2024cites this paper
• Hyperspectral retinal imaging in Alzheimer’s disease and age-related macular degeneration: a review

  2024cites this paper
• Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease

  2024cites this paper
• Circadian rhythm in neurodegenerative disease: the role of RNA modifications and potential application of RNA-based therapeutics

  2024cites this paper
• Microglial Circadian Rhythms and Neurodegenerative Diseases.

  2024cites this paper
• Neurodegenerative biomarkers in different chambers of the eye relative to plasma: an agreement validation study

  2024cites this paper
• Changes in Intrinsically Photosensitive Retinal Ganglion Cells, Dopaminergic Amacrine Cells, and Their Connectivity in the Retinas of Lid Suture Myopia

  2024cites this paper
• Color Fundus Photography and Deep Learning Applications in Alzheimer Disease

  2024cites this paper
• Basics, benefits, and pitfalls of pupillometers assessing visual function

  2024cites this paper
• Progress in Visual Dysfunction and Retinopathy in Atypical Parkinson’s Syndrome

  2024cites this paper
• Circadian Clocks, Daily Stress, and Neurodegenerative Disease.

  2024cites this paper
• The Crosstalk Between Amyloid-β, Retina, and Sleep for the Early Diagnosis of Alzheimer’s Disease: A Narrative Review

  2024cites this paper
• Chlamydia pneumoniae in Alzheimer's disease pathology

  2024cites this paper
• Normal-Tension Glaucoma and Potential Clinical Links to Alzheimer’s Disease

  2024cites this paper
• Retinal peri-arteriolar versus peri-venular amyloidosis, hippocampal atrophy, and cognitive impairment: exploratory trial

  2024cites this paper
• Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer’s disease

  2024cites this paper
• Circadian regulation of microglia function: Potential targets for treatment of Parkinson's Disease.

  2024cites this paper
• The eyes have it: pupillary assessment as a measure of sleep and circadian health

  2024cites this paper
• Deep Learning and Machine Learning Algorithms for Retinal Image Analysis in Neurodegenerative Disease: Systematic Review of Datasets and Models

  2024cites this paper
• Enhancing foveal avascular zone analysis for Alzheimer’s diagnosis with AI segmentation and machine learning using multiple radiomic features

  2024cites this paper
• Melanopsin retinal ganglion cell function in Alzheimer's vs. Parkinson's disease an exploratory meta-analysis and review of pupillometry protocols.

  2024cites this paper
• Transport of β-amyloid from brain to eye causes retinal degeneration in Alzheimer’s disease

  2024cites this paper
• The cognitive impact of light: illuminating ipRGC circuit mechanisms

  2024cites this paper
• Exploring Advancements in Early Detection of Alzheimer's Disease with Molecular Assays and Animal Models.

  2024cites this paper
• The Eyes Have It - Pupillary Assessment as a Measure of Sleep and Circadian Health.

  2024cites this paper
• Neuronal and glial vulnerability of the suprachiasmatic nucleus in tauopathies: evidence from human studies and animal models

  2024cites this paper
• Association of lamina cribrosa thickness and hippocampal volume in Alzheimer's disease patients

  2024cites this paper
• Chromatic pupillometry for evaluating melanopsin retinal ganglion cell function in Alzheimer’s disease and other neurodegenerative disorders: a review

  2024cites this paper
• Hyperspectral Retinal Imaging as a Non-Invasive Marker to Determine Brain Amyloid Status

  2024cites this paper
• Alzheimer's Disease Pathophysiology in the Retina.

  2024cites this paper
• Glaucoma‐inducing retinal ganglion cell degeneration alters diurnal rhythm of key molecular components of the central clock and locomotor activity in mice

  2024cites this paper
• Preservation of Intrinsically Photosensitive Retinal Ganglion Cells (ipRGCs) in Late Adult Mice: Implications as a Potential Biomarker for Early Onset Ocular Degenerative Diseases

  2024cites this paper
• Alterations in zinc, copper, and iron levels in the retina and brain of Alzheimer's disease patients and the APP/PS1 mouse model

  2024cites this paper
• Application of optical coherence tomography in neurodegenerative diseases: a focus on Parkinson’s, Alzheimer’s, and Schizophrenia in Bulgarian patients

  2024cites this paper
• Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status

  2024cites this paper
• Retinotopic degeneration of the retina and optic tracts in autosomal dominant Alzheimer's disease

  2023cites this paper
• Altered circadian behavior and light sensing in mouse models of Alzheimer’s disease

  2023cites this paper
• Multimodal investigation of melanopsin retinal ganglion cells in Alzheimer's disease

  2023cites this paper
• Natural products: protective effects against ischemia-induced retinal injury

  2023cites this paper
• Structure, Function, and Molecular Landscapes of the Aging Retina.

  2023cites this paper
• Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer’s disease

  2023cites this paper
• Retinal thickness and vascular parameters using optical coherence tomography in Alzheimer’s disease: a meta-analysis

  2023influential citation
• Retinal imaging in animal models: Searching for biomarkers of neurodegeneration

  2023cites this paper
• Retinal Alterations as Potential Biomarkers of Structural Brain Changes in Alzheimer’s Disease Spectrum Patients

  2023cites this paper
• The Eye as a Diagnostic Tool for Alzheimer’s Disease

  2023cites this paper
• Chronic Sleep Disturbances Alters Sleep Structure and Tau Phosphorylation in AβPP/PS1 AD Mice and Their Wild-Type Littermates

  2023cites this paper
• The Cleavage-Specific Tau 12A12mAb Exerts an Anti-Amyloidogenic Action by Modulating the Endocytic and Bioenergetic Pathways in Alzheimer’s Disease Mouse Model

  2023cites this paper
• Imaging Amyloid and Tau in the Retina: Current Research and Future Directions

  2023cites this paper
• Comparison of Retinal Structural and Neurovascular Changes between Patients with and without Amyloid Pathology

  2023cites this paper
• Retinal pathological features and proteome signatures of Alzheimer’s disease

  2023cites this paper
• Circadian disruption and sleep disorders in neurodegeneration

  2023cites this paper
• The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer’s-related disease and preserving cognition

  2023cites this paper
• Circadian rhythm disruption and retinal dysfunction: a bidirectional link in Alzheimer's disease?

  2023cites this paper
• Sleep Disorders and Alzheimer's Disease pathophysiology: the role of the Glymphatic System. A Scoping Review.

  2023cites this paper
• The Major Hypotheses of Alzheimer’s Disease: Related Nanotechnology-Based Approaches for Its Diagnosis and Treatment

  2023cites this paper
• Potential Retinal Biomarkers in Alzheimer’s Disease

  2023cites this paper
• Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions

  2023cites this paper
• Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease

  2023cites this paper
• Altered Clock Gene Expression in Female APP/PS1 Mice and Aquaporin-Dependent Amyloid Accumulation in the Retina

  2023cites this paper
• Retinale optische Kohärenztomographie-Biomarker bei demenziellen Erkrankungen

  2023cites this paper
• The Photic Blink Reflex as an Index of Photophobia.

  2023cites this paper